Zepbound is the new weight loss medication from Eli Lilly. Patients are losing on average 20% of their body weight in just over a year. Simply amazing.

If you're considering Zepbound for weight loss, this video series is for you. In this first video, we discuss the foundational knowledge needed to consider Zepbound as a potential treatment for obesity.

Of course, Zepbound is the same medication as Mounjaro, which is the drug Tirzepatide. will discuss the role of the GLP receptor in human body, and how Zepbound affects our physiology to help lose weight.

Eli Lilly has hit a homerun with this medication. it is helping so many people achieve dramatic weightloss and improve their overall health.

Zepbound is generally better tolerated than Ozempic (Semaglutide) and leads to better weight loss.

Follow this video series to learn more. Emerge is a telehealth Obesity Management and Urgent Care medical practice. https://www.emergefor.me/

Check out our Facebook group to support your weight loss journey!   / 543288764320370  


#zepbound #weightloss #emergeforme #mounjaro #semaglutide #wegovy #ozempic #glp1 #glp1medication #weightlosstransformation #2024